Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × Oxaliplatin × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 71 Stomach Neoplasms 58 Rectal Neoplasms 36 Colonic Neoplasms 29 Pancreatic Neoplasms 25 Esophageal Neoplasms 23 Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 19 Adenocarcinoma 19 Neoplasm Metastasis 14 Cholangiocarcinoma 14 Carcinoma, Non-Small-Cell Lung 12 Adenocarcinoma Of Esophagus 12 Ovarian Neoplasms 10 Biliary Tract Neoplasms 10 Gastrointestinal Neoplasms 8 Gallbladder Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Locally Advanced Rectal Cancer 5 Recurrence 4 Lymphoma 4 Esophageal Squamous Cell Carcinoma 4 Endometrial Neoplasms 4 Carcinoma 4 Bile Duct Neoplasms 4 Advanced Solid Tumors 4 Triple Negative Breast Neoplasms 3 Peritoneal Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡